Pages that link to "Q34756466"

The following pages link to The effect of base mismatches in the substrate recognition helices of hammerhead ribozymes on binding and catalysis (Q34756466):

Displaying 29 items.

• A general purpose RNA-cleaving DNA enzyme (Q28315030) (← links)
• Hammerhead redux: does the new structure fit the old biochemical data? (Q31147227) (← links)
• The virtues of self-binding: high sequence specificity for RNA cleavage by self-processed hammerhead ribozymes (Q33614060) (← links)
• Efficient Silencing of Gene Expression by an ASON–Bulge–DNAzyme Complex (Q33872170) (← links)
• Measurements of weak interactions between truncated substrates and a hammerhead ribozyme by competitive kinetic analyses: implications for the design of new and efficient ribozymes with high sequence specificity (Q33891817) (← links)
• Effects of Pathogenic Variations in the Human Rhodopsin Gene (hRHO) on the Predicted Accessibility for a Lead Candidate Ribozyme (Q33917242) (← links)
• Development of hammerhead ribozymes to modulate endogenous gene expression for functional studies. (Q34157406) (← links)
• Cleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects (Q34635276) (← links)
• The effect of structure in a long target RNA on ribozyme cleavage efficiency (Q34646173) (← links)
• Variables and strategies in development of therapeutic post-transcriptional gene silencing agents (Q35110219) (← links)
• Preservation of photoreceptor morphology and function in P23H rats using an allele independent ribozyme. (Q35603911) (← links)
• Specificity of hammerhead ribozyme cleavage (Q35903865) (← links)
• Modification of globin gene expression by RNA targeting strategies (Q36427146) (← links)
• Use of intrinsic binding energy for catalysis by an RNA enzyme (Q36544193) (← links)
• Design of efficient DNAzymes against muscle AChR alpha-subunit cRNA in vitro and in HEK 293 cells. (Q37331642) (← links)
• Improved design of hammerhead ribozyme for selective digestion of target RNA through recognition of site-specific adenosine-to-inosine RNA editing (Q37581533) (← links)
• Unexpected anisotropy in substrate cleavage rates by asymmetric hammerhead ribozymes. (Q39716864) (← links)
• Optimisation of the 10-23 DNAzyme-substrate pairing interactions enhanced RNA cleavage activity at purine-cytosine target sites (Q39758686) (← links)
• Are engineered proteins getting competition from RNA? (Q41080789) (← links)
• Chemical engineering of RNase resistant and catalytically active hammerhead ribozymes. (Q41672853) (← links)
• Selective DNAzyme-mediated cleavage of AChR mutant transcripts by targeting the mutation site or through mismatches in the binding arm. (Q41981720) (← links)
• A strategy for developing a hammerhead ribozyme for selective RNA cleavage depending on substitutional RNA editing (Q42288544) (← links)
• In vitro analysis of ribozyme-mediated knockdown of an ADRP associated rhodopsin mutation (Q42953784) (← links)
• Hammerhead ribozyme kinetics (Q43206267) (← links)
• Ribozyme targeting of HER-2 inhibits pancreatic cancer cell growth in vivo (Q43723222) (← links)
• Designing and characterizing hammerhead ribozymes for use in AAV vector-mediated retinal gene therapies (Q43908574) (← links)
• Addition of an extra substrate binding site and partial destabilization of stem structures in HDV ribozyme give rise to high sequence-specificity for its target RNA. (Q44773703) (← links)
• Ribozymes targeted to stearoyl-ACP delta9 desaturase mRNA produce heritable increases of stearic acid in transgenic maize leaves (Q77374040) (← links)
• Designing ribozymes for the inhibition of gene expression (Q77529654) (← links)